Objective : To determine the association of blood pressure and other biochemical parameters with type 2 DM subjects.
Introduction
Type -2 diabetes mellitus, one of the top five causes for m o rtality, a f fected more than 170 million individuals worldwide. 1 More than 80% of the deaths in diabetic subjects are attributed to Cardiovascular diseases. 2 Essential hypertension is common and is an important risk factor for coronary heart disease, stroke, atherosclerosis and peripheral vascular disease 3 . There is a substantial evidence to say that the prevalence of hypertension in diabetics is twice as common as compared to non-diabetics 4 . Both hypertension and diabetes predisposes to the development of cardiovascular diseases (CVD) 5 . When hypertension coexists with diabetes, the risk of CVD is elevated by 75%, which further contributes to the overall morbidity and mortality of an already high risk population 6 , Hypertension in Type-2 diabetic patients clusters with other CVD risk factors such as microalbuminuria, central obesity, insulin resistance, dyslipidaemia, h y percoagulation, increased inflammation and left ventricular hypertrophy 7 . This clustering of risk factors in diabetic patients ultimately results in the development of CVD, which is the major cause of premature mortality in these patients. Studies of hypertension control in diabetes show a clear and consistent effect: Improved control of blood pressure leads to substantially reduced risks for cardiovascular events and death 8 Over the last few decades there has been increasing interest in the clinical a s sociation between hypertension and diabetes 9 . A Moroccan representative sample aged 20 years old conducted during the year 2000, on cardiovascular risk factors showed that the prevalence of diabetes was 6.6%, the prevalence of hypertension was 33.6% (30.2% for men and 37.0% for women) and the prevalence of cardiovascular risk factors was high within the Moroccan population .10 Very recently, the results of the ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial, which randomized people with diabetes to a target systolic BP value of either less than 140 mm Hg or less than 120 mm Hg, were published. 11 Hyperinsulinemia is in -itself an independent cause of atherosclerosis as it promotes atherogenic dyslipidaemia 12 t h at enhanced CVD r i sk in such individuals. There are reports of increased risk of hypertension in type2 diabetic subjects with deteriorating glycaemic control 13 .
The strategy adopted in this study is to explore the effect of the anthropometric and biochemical confounders on insulin secretory defect in T2DM.
Methods
This was a observational study with case control design. A total of 63 type 2 DM patients and 90 healthy controls were studied between 30-60 years of age Subjects were selected f r om the Out-Patient This study was conducted to assess glucose insulin ratio and blood pressure among the normal to overweight BMI in healthy control group and insulin resistance type 2 DM subjects. The statistical significance of differences between the values was assessed by 't' test. A two-tailed p value of <0.05 was considered statistically significant.
Results of Anthropometric and Clinical characteristics of the study subjects were expressed as Mean±SD, T test was performed as the test of significance at 5% significance level. n=number of subjects, BMI=Body mass index, WHR=Waist hip ratio, S_BP= Systolic blood pressure and D_BP= Diastolic blood pressure, Glu:Ins= Glucose Insulin ratio; Results of Glycemic status and insulinemic status among the study subjects. of were expressed as Mean ± SD as appropriate't' test and Median (range). Mann-Whitney 'U' test was performed as the test of significance at 5% significance level. n = number of subjects, F_Glu-= Fasting glucose; PP_Glu=post prandial (2 hours after breakfast) glucose; Ins: Glu=Insulin Glucose ratio; HOMA-B %= B cell function assessed by homeostasis model assessment. Pearson's correlation analysis were performed. p<0.05 are considered as statistically significant; n= number of subjects. HOMA-B %= B cell function assessed by homeostasis model assessment and GINR= Glucoseinsulin ratio.
Results
A total of 153 subjects were included in study of which 63 belonged to insulin resistance T2 DM group and 90 were healthy Controls. The median (range) of the glucose and insulin ratio of the study group were Control 0.37 (0.06 -1.52) and T2DM 0.54 (0.17 -2.33). There was significant difference in between Control vs. T2DM (P<0.001). Waist-hip ratio [cm, (Mean±SD) in Control, 0.88 ± 0 . 06and in T2 DM, 0.94±0.12]. There was significantly higher association in T2DM as compared to control subjects (p<0.001). Type 2 DM has significant risk of hypertension S-BP[(Mean±SD) in Control,(110 ± 15.50) and in T2 DM,(117±16.13)]. There was significant in T2DM as compared to control subjects (p=0.008). D-BP[(Mean±SD) in Control,(72±11.29)and in T2 DM, (78±9.78.) Significantl association was found in T2DM as compared to control subjects ( p=0.008). Significant positive correlation were found between HOMA% B and fasting insulin (r=0.591, p<0.001), and a significant negative association was found with fasting glucose (r=-0.311, p=0.003), GINR (r = -0.707, p <0.001) in the Control group (Ta b le 3).
Discussion
The capacity for insulin secretion at diagnosis of type 2 diabetes is largely preserved, but the response to cell secretagogues is not equivalent to that seen in nondiabetic subjects. 15 the insulin secretory defect could be genetically determined as proposed in Kearns-Sayre syndrome 16 , in which there is a decrease in cell mass rather than function. Determination of the contribution of a reduction of cell secretion is complicated by parallel changes in insulin resistance that accompany onset of type 2 diabetes 17 . Assessment of insulin secretion can be made by mathematical modeling (homeostatic model assessment), which indicates that insulin secretion is reduced at the time of diagnosis and further diminishes during the course of the disease. 18 BMI seems to be a major determinant of insulin secretion in Bangladeshi subjects 19 . In non-diabetic controls (who belonged to normal to overweight BMI range), B-cell function was not affected by BMI as reported in nonobese healthy subjects by Martinez-Abundis et al in a Maxican population 20 . In a Bangladeshi population, nonobese diabetic subjects (BMI of <25 kg/m 2 ) did not show any hypersecretion of insulin. Hyperinsulinemia has been reported in obese nondiabetic Caucasians. These observations reemphasize the importance of body weight in the regulation of peripheral insulin levels and it becomes more and more important in higher degrees of BMI. Hyperinsulinemia is necessary to the hormone secondary to obesity 21 . Insulin secretion (HOMA%B) was significantly lower in diabetic as compared to control subjects [HOMA%B, median (range), 71 (4.90 -391) vs 180 (59 -634) p<0.001]. (Table 2) Hyperglycemia (even in a moderate range) appears to be a very sensitive determinant of insulin secretion in T2DM. In contrast to nondiabetic subjects where insulin secretion is linearly related to peripheral glucose, hyperglycemia over a t hreshold level has a suppressing effect in T2DM 22 . This deleterious effect is often referred to as "glucose toxicity" or "glucose desensitization". The negative impact of glucose has been clearly shown when plasma glucose concentration reach the range associated with diabetes 23 . Asakawa et al have also suggested that diabetic patients with poor glycemic control for a long period show suppressed insulin secretion due to glucotoxicity 24 .
It is interesting to observe that body weight within a range of normal to overweight only BMI representing general obesity was the significant determinant of insulin sensitivity in control and diabetic population. In this range WHR (representing central obesity) was not found to be correlated with any index of insulin sensitivity.
In a cohort studies and clinical trials suggest that higher levels of glucose and insulin may contribute to the development of hypertension independent of obesity and other established hypertension risk factors 25 . Hypertension is a common condition which usually coexists with DM and aggravates DM complications and cardiovascular morbidity and mortality. In our study, both SBP and DBP shows significant association with type 2 DM.(S-BP, mean±SD, p= 0.003,D-BP, mean±SD, p= 0.008).
One reason for the poor prognosis in patients with both diabetes and ischemic heart disease seems to be an enhanced myocardial dysfunction leading to accelerated heart failure due to diabetic cardiomyopathy. 26 
Conclusion
The type 2 diabetic subjects are at a higher CVD risk as compared to control subjects at comparable levels of biochemical parameters, maintaining BD within normal level and other parameters with type 2 diabetes has dramatic benefits and should be the first priority in diabetes care.
